Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
370 ARTÍCULOS , VIENDO DEL 301 AL 315
Prati F, Bottegoni G, Bolognesi ML, Cavalli A.
J Med Chem. 2018 Feb 8;61(3):619-637. doi: 10.1021/acs.jmedchem.7b00393. Epub 2017 Aug 8.
Three-Dimensional Models of the Human Brain Development and Diseases
Jorfi M, D'Avanzo C, Kim DY, Irimia D.
Adv Healthc Mater. 2018 Jan;7(1):10.1002/adhm.201700723. doi: 10.1002/adhm.201700723. Epub 2017 Aug 28.
Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer's Disease
Voytyuk I, De Strooper B, Chávez-Gutiérrez L.
Biol Psychiatry. 2018 Feb 15;83(4):320-327. doi: 10.1016/j.biopsych.2017.08.001. Epub 2017 Aug 10.
Therapeutic peptides for CNS indications: Progress and challenges
Morimoto BH.
Bioorg Med Chem. 2018 Jun 1;26(10):2859-2862. doi: 10.1016/j.bmc.2017.09.011. Epub 2017 Sep 9.
Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise
van Dyck CH.
Biol Psychiatry. 2018 Feb 15;83(4):311-319. doi: 10.1016/j.biopsych.2017.08.010. Epub 2017 Aug 24.
Kaushik V, Smith ST, Mikobi E, Raji MA.
Am J Alzheimers Dis Other Demen. 2018 Mar;33(2):73-85. doi: 10.1177/1533317517734352. Epub 2017 Oct 3.
Hathout RM, El-Ahmady SH, Metwally AA.
Nat Prod Res. 2018 Dec;32(24):2873-2881. doi: 10.1080/14786419.2017.1385017. Epub 2017 Oct 12.
How efficient are rodent models for Alzheimer's disease drug discovery?
Guo B, Zhou Q.
Expert Opin Drug Discov. 2018 Feb;13(2):113-115. doi: 10.1080/17460441.2018.1398730. Epub 2017 Oct 31.
A very low dose of rivastigmine-induced Pisa syndrome in a clozapine-treated patient
Chao PC, Li JC, Yeh TC, Yeh CB.
Aust N Z J Psychiatry. 2018 Feb;52(2):204-205. doi: 10.1177/0004867417741983. Epub 2017 Nov 9.
Tricco AC, Ashoor HM, Soobiah C, Rios P, Veroniki AA, Hamid JS, Ivory JD, Khan PA, Yazdi F, Ghassemi M, Blondal E, Ho JM, Ng CH, Hemmelgarn B, Majumdar SR, Perrier L, Straus SE.
J Am Geriatr Soc. 2018 Jan;66(1):170-178. doi: 10.1111/jgs.15069. Epub 2017 Sep 29.
Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease
Kurochkin IV, Guarnera E, Berezovsky IN.
Trends Pharmacol Sci. 2018 Jan;39(1):49-58. doi: 10.1016/j.tips.2017.10.008. Epub 2017 Nov 10.
Caregiver burden regarding elderly with bipolar disorder: An underrecognized problem
Santos GD, Ladeira RB, Almeida JG, Aprahamian I, Forlenza OV, Lafer B, Nunes PV.
Gen Hosp Psychiatry. 2018 Mar-Apr;51:134-135. doi: 10.1016/j.genhosppsych.2017.10.011. Epub 2017 Nov 7.
Renn BN, Asghar-Ali AA, Thielke S, Catic A, Martini SR, Mitchell BG, Kunik ME.
Am J Geriatr Psychiatry. 2018 Feb;26(2):134-147. doi: 10.1016/j.jagp.2017.09.027. Epub 2017 Oct 10.
Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease
Seo EJ, Fischer N, Efferth T.
Pharmacol Res. 2018 Mar;129:262-273. doi: 10.1016/j.phrs.2017.11.030. Epub 2017 Nov 24.
Intranasal insulin in Alzheimer's disease: Food for thought
Chapman CD, Schiöth HB, Grillo CA, Benedict C.
Neuropharmacology. 2018 Jul 1;136(Pt B):196-201. doi: 10.1016/j.neuropharm.2017.11.037. Epub 2017 Nov 24.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.